Insider Buying: Kailera Therapeutics (NASDAQ:KLRA) Director Purchases 1,562,500 Shares of Stock

Kailera Therapeutics, Inc. (NASDAQ:KLRA) Director Adam Koppel acquired 1,562,500 shares of Kailera Therapeutics stock in a transaction that occurred on Monday, April 20th. The shares were purchased at an average price of $16.00 per share, with a total value of $25,000,000.00. Following the purchase, the director owned 22,583,268 shares in the company, valued at $361,332,288. This represents a 7.43% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Kailera Therapeutics Trading Down 5.3%

Kailera Therapeutics stock traded down $1.39 during midday trading on Monday, reaching $24.61. The company’s stock had a trading volume of 1,340,343 shares. Kailera Therapeutics, Inc. has a 52-week low of $23.69 and a 52-week high of $28.23.